AKT1 and hepatocellular carcinoma: MV-3-gal was given to Huh-7 hepatocellular carcinoma (HCC) cell lines, which decreased cell division, stop cell cycle, and colony formation depending on the dose via inhibiting the MAPK, MMP, and PTEN/Akt pathways [63].